| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.59 | 0.02 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.6 | 0.03 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |